Cadrenal Therapeutics CVKD
NASDAQ CVKD
$1.09 -0.03 (-2.68%)
At close: Sep 29, 2026 · 4:00 PM EDT

Cadrenal Therapeutics (CVKD) EPS (Basic) (2022 - 2026)

Updated

Cadrenal Therapeutics (CVKD) reported EPS (Basic) of -$1.14 for Q2 2026, compared with -$1.87 a year earlier.

Analysis

Cadrenal Therapeutics (CVKD) EPS (Basic) (2022 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Cadrenal Therapeutics' EPS (Basic) came in at -$4.05; for FY2023, it came in at -$9.29.

  • By year, EPS (Basic) came in at -$12.76 in FY2022.
  • The Q2 2026 figure ranks as the highest quarterly EPS (Basic) since Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 2.30
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.04
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -0.54
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 1.68
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 1.87
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 4.40
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -8.44
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -0.04
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 4.34
10 Cadrenal Therapeutics 3.47 Mn -9.15 Mn - -1.14
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.14
Jun 30, 2025 -1.87
Sep 30, 2024 -2.18
Jun 30, 2024 -2.24
Mar 31, 2024 -1.56
Dec 31, 2023 -1.27
Sep 30, 2023 -1.01
Jun 30, 2023 -1.28
Mar 31, 2023 -7.20
Dec 31, 2022 -9.52
Sep 30, 2022 -1.91
Jun 30, 2022 -0.95
Mar 31, 2022 -0.35
API Access

Cadrenal Therapeutics EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=CVKD&period=max&api_key=YOUR_API_KEY